Fresh Rounds

Galaxy Diagnostics, Inc. funding

Galaxy Diagnostics, Inc., a biotechnology company based in Durham, NC, filed a Form D with the SEC on June 3, 2026 and reported $3M raised of a $5.7M offering.

Amount raised$3M
Offering size$5.7M
Filed with the SECJune 3, 2026
First saleMay 1, 2026
IndustryBiotechnology
SecuritiesEquity
LocationDurham, NC
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far45
Minimum investment—
Revenue rangeDecline to Disclose

Other health care rounds in North Carolina